Oral cancer represents up to 5% of all malignant tumors in the Western Hemisphere, but the process by which oral epithelial cells become invasive has not been studied in detail. Recent data obtained in other epithelial malignancies suggests an important role for stromal cells in modulating keratinocyte invasion, but the role of stromal cells in oral cancer is not understood. Specifically, the role of proteinases secreted by epithelial cells and their regulation by stromal cell factors has not yet been elucidated. In addition, several studies have determined that human papillomavirus DNA can be detected in a large subset of oral cancers. However, the role that HPV plays in the pathogenesis of these tumors is not understood, and little is known of biological differences between HPV-positive and HPV-negative oral cancers. This is a three- phase study. In the first phase, the expression of proteinases (MMP-2, MMP-3, MMP-9 and urokinase plasminogen activator) at the mRNA and protein levels will be characterized in archival oral tissue specimens ranging from benign to invasive cancer. It will be determined if HPV DNA is present in the tissues, and if the two known oncogenes, E6 and E7, are being expressed. Based on these results, in the second phase, oral cancer tissues collected in a prospective manner, along with accompanying clinical data, will be studied to determine the prognostic significance of proteinase and HPV gene expression. In the third phase, an in vitro invasion model and a nude mouse tumor model will be used to study mechanisms of interaction between epithelial and stromal cells in modulating invasion by oral keratinocytes. The role of epithelial and stromal interactions in vitro will be studied by incorporating oral fibroblasts, derived from normal oral tissue or oral cancer tissue, into the Matrigel invasion model. Proteinase and growth factor expression by keratinocytes and fibroblasts will be characterized. Modulation of proteinase expression in different keratinocyte cell lines by different growth factors will be measured. Then proteinase and growth factor expression in nude mouse tumors induced by the HSC3 oral cancer cell line will be characterized. Mouse fibroblast lines from normal and cancerous tissues as described above will be established and studied for their ability to modulate invasion of the tumor cells in the Matrigel model. Factors of interest will be transfected into oral keratinocyte cell lines that have been shown to be nontumorigenic in this model. The transfected cells will then be studied in the nude mouse, as well as in the Matrigel in model, to determine if expression has altered their invasive capability and tumorigenicity. Together, it is expected that the data generated by these studies will provide important new information on the mechanism of interaction between epithelial and stromal cells in the pathogenesis of oral cancer, as well as provide information on the prognostic value of detection of factors mediating these interactions. Ultimately it is expected that this information will be of value in prevention and/or treatment of this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Specialized Center (P50)
Project #
1P50DE011912-01
Application #
5210289
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Bortoluzzi, Marcelo C; Yurgel, Liliane S; Dekker, Nusi P et al. (2004) Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:698-704
Sethi, Neerja; Palefsky, Joel (2003) Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type 1 thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein. Hum Gene Ther 14:45-57
Stern, Robert; Shuster, Svetlana; Neudecker, Birgit A et al. (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 276:24-31
Mio, Kazuhiro; Stern, Robert (2002) Inhibitors of the hyaluronidases. Matrix Biol 21:31-7
Regezi, Joseph A; Ramos, Daniel M; Pytela, Robert et al. (2002) Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 38:332-6
Nicoll, Steven B; Barak, Ory; Csoka, Antonei B et al. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem Biophys Res Commun 292:819-25
Shuster, Svetlana; Frost, Gregory I; Csoka, Antonei B et al. (2002) Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer 102:192-7
Mio, K; Csoka, A B; Nawy, S S et al. (2001) Detecting hyaluronidase and hyaluronidase inhibitors. Hyaluronan-substrate gel and -inverse substrate gel techniques. Methods Mol Biol 171:391-7
Lin, G; Stern, R (2001) Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett 163:95-101
Nawy, S S; Csoka, A B; Mio, K et al. (2001) Hyaluronidase activity and hyaluronidase inhibitors. Assay using a microtiter-based system. Methods Mol Biol 171:383-9

Showing the most recent 10 out of 32 publications